Introduction
Traditional Cognitive Batteries for MS
The Development of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
Historical Background
Development and Content
Symbol Digit Modalities Test (SDMT)
California Verbal Learning Test-II (CVLT-II)
Brief Visuospatial Memory Test–Revised (BVMT-R)
International Validity
Method
Systematic Literature Search
Search terms |
---|
“multiple sclerosis” OR “ms” AND |
“Brief International Cognitive Assessment for Multiple Sclerosis” OR “BICAMS” |
Eligibility Criteria
Data Extraction
Quality Assessment
Statistical Analysis
Compliance with Ethics Statement
Results
Systematic Review of BICAMS Validation Studies
Systematic Review Overview
Study (first author) | No. of subjects | Age, years Mean (SD) | Gender % Female | Education, years Mean (SD) | % Type MS (RR/SP/PP/PR/CIS) | Disease duration Mean (SD) | EDDS Mean (SD) | SDMT | CVLT-II | BVMT-R |
---|---|---|---|---|---|---|---|---|---|---|
Costers [40] | ||||||||||
MS | 97 | 45.42 (9.24) | 70% | 14.28 (1.86) | 84/12/4/0/0 | 12.97 (7.16) | 3.50 (2.50) | 52.1 (13.1) | 60.1 (12.9) | 25.4 (29) |
HC | 97 | 43.52 (12.69) | 77% | 14.69 (1.61) | – | – | – | 61 (10.2) | 61.3 (60) | 28.2 (5.1) |
Dusankova [36] | ||||||||||
MS | 369 | 34 (10) | 68% | 14 [3] | 68/26/3/3/0 | 8 (7) | 3 (1.5) | 50 (13) | 60 (8) | 23 (7) |
HC | 134 | 34 (9) | 71% | 14 (2.5) | – | – | – | 65 (9) | 52 (11) | 29 (4) |
Eshaghi [41] | ||||||||||
MS | 156 | 34.05 (9.09) | 71% | 14.13 (2.97) | 80/20/0/0/0 | 6.07 (5.08) | 2.5a (7.5)a | 43.93 (16.55) | 49.23 (10.39) | 20.88 (7.65) |
HC | 90 | 33.65 (9.48) | 63% | 14.27 (3.56) | – | – | – | 55.58 (16.48) | 55.31 (8.46) | 25.01 (7.38) |
Giedraitienė [42] | ||||||||||
MS | 50 | 38.8 (10.2) | 32% | 15.9 (2.8) | 88/6/2/0/4 | 11.7 (9.2) | 3.3 (1.3) | 42.7 (13.9) | 55.9 (10) | 23.1 (7) |
HC | 20 | 36.7 (16.4) | 10% | 17.5 (3.5) | – | – | – | 57.7 (11.5) | 65.7 (5.9) | 29.6 (4.1) |
Goretti [43] | ||||||||||
MS | – | – | – | – | – | – | – | – | – | – |
HC | 23 and 243 | 38.9 (13) and 38.2 (13.1) | 66% 65% | 14.9 (3) | – | – | – | 56.3 (11.3) | 56.3 (9) | 27.9 (6.1) |
Niccolai [44] | ||||||||||
MS | 192 | 41.4 (10.8) | 74% | 12.3 (3.5) | 100/0/0/0/0 | 12.7 (1.7) | 2.7 (1.7) | 46.4 (12.8) | 49.9 (12.1) | 23.7 (8) |
HC | 200 | – | – | – | – | – | – | 56.3 (11.3) | 56.3 (9) | 27.9 (6.1) |
Niino [45] | ||||||||||
MS | 156 | 41.4 (9.3) | 69% | 14.1 (1.9) | 88/11/1/0/0 | 2.4 (2.0) | 47.9 (14) | 48.6 (12.6) | 23.5 (8.4) | |
HC | 126 | 39.3 (11.9) | 72% | 14.3 (1.6) | – | – | – | 61 (9.5) | 55.7 (10.5) | 28.3 (5.4) |
O’Connell [46] | ||||||||||
MS | 67 | 43.9 (12.1) | 73% | 13.6 (2.7) | 70/28/2/0/0 | 10.2 (8.4) | 1.8 (0.9) | 46 (12.9) | 45.3 (10.2) | 17.9 (7.1) |
HC | 66 | 42.7 (12.8) | 68% | 14.1 (3.1) | – | – | – | 56.1 (10.6) | 53.6 (9.1) | 20.9 (6.5) |
Ozakbas [47] | ||||||||||
MS | 173 | 37.5 (10.7) | 71% | 13.9 (7.3) | 151/18/4/0/0 | 9.2 6.1) | 2.4 (1.7) | 43.2 (12.5) | 45.7 (11.3) | 16.9 (8.5) |
HC | 153 | 36.9 (8.9) | 71% | 15.4 (8.8) | – | – | – | 53.5 (9.5) | 53.9 (7.7) | 22.5 (9.2) |
Polychroniadou [48] | ||||||||||
MS | 44 | 40.2 (9.9) | 61% | 14.1 (4.8) | 77/12/9/0/2 | RR 9.6 (3.7); SP 7.5 (3.7); PP 6.0 (2.6); CIS 1.6 (0.5) | – | 45 (17.2) | 55.5 (12.3) | 18.5 (8.3) |
HC | 79 | 36.2 (10.6) | 61% | 15.4 (5.5) | – | – | – | 61.4 (13.1) | 60.5 (10.7) | 22.1 (6.5) |
Sandi [49] | ||||||||||
MS | 65 | 41.9 (8.9) | 75% | n = 31 < 12 years; n = 34 ≥ 13 years | 100/0/0/0/0 | 11.1 (7.6) | 2.5 (1.8) | 55.62 (15.48) | 55.37 (10.71) | 22.54 (8.54) |
HC | 65 | 40.9 (11.8) | 75% | n = 31 < 12 years; n = 34 ≥ 13 years | – | – | – | 66.82 (12.44) | 59.03 (8.29) | 26.68 (5.56) |
Spedo [50] | ||||||||||
MS | 58 | 41.2 (12.2) | 69% | 12.7 (5.2) | 100/0/0/0/0 | 8.3 (6.6) | 2.2 (2) | 35.9 (16.1) | 42.1 (12.4) | 19.9 (8.6) |
HC | 58 | 40.3 (11.9) | 55% | 12.5 (3.6) | – | – | – | 47 (13) | 53.4 (10.8) | 23.8 (7.7) |
Strober [10] | ||||||||||
MS | 65 | 45 (9.9) | 80% | 14 (2.4) | 72/22/3/1.5/1.5 | 10.2 (7.6) | 3.3 (1.7) (n = 54) | 48.4 (10.1) | 48.1 (9.8) | 26.2 (5.8) |
HC | 46 | 45.2 (9.9) | 85% | 15 (1.8) | – | – | – | 62.1 (10.7) | 56.7 (8.1) | 21.1 (6.4) |
Vanotti [51] | ||||||||||
MS | 50 | 43.42 (10.17) | 74% | 14.86 (2.78) | 78/18/4/0/0 | 13.06 (9.08) | 3.29 (2.55) | 45.14 (16.07) | 50.92 (12.37) | 20.7 (7.74) |
HC | – | – | – | – | – | – | – | – | – | – |
Vanotti [52] | ||||||||||
MS | 50 | 43.42 (10.17) | 74% | 14.86 (2.78) | 78/18/4/0/0 | 13.06 (9.08) | 3.29 (2.55) | 45.14 (16.07) | 50.92 (12.37) | 20.7 (7.74) |
HC | 100 | 42.37 (10.07) | 75% | 14.94 (2.49) | – | – | – | 56.71 (10.85) | 60.88 (10.46) | 23.44 (5.84) |
Walker [53] | ||||||||||
MS | 57 | 45.44 (9.93) | 72% | 15.44 (2.68) | 77/16/7/0/0 | 10.11 (7.72) | 2.70 (1.85) | 49.65 (10.78) | 51.63 (10.05) | 24.6 (6.54) |
HC | 51 | 41.92 (10.78) | 86% | 16.31 (2.11) | – | – | – | 59.11 (8.46) | 57.72 (7.97) | 29.8 (3.63) |
Study | Country | Number of people with MS in study | Number of people with MS in country | Percentage in study (%) |
---|---|---|---|---|
Costers [40] | Belgium | 97 | 12,000 | 0.81 |
Dusankova [36] | Czech Republic | 369 | 16,000 | 2.31 |
Eshaghi [41] | Iran | 156 | 50,000 | 0.31 |
Giedraitienė [42] | Lithuania | 50 | 2621 | 1.91 |
Goretti [43] Niccolai [44] | Italy | 23 | 68,000 | 0.03 |
192 | ||||
Niino [45] | Japan | 156 | 12,000 | 1.30 |
O’Connell [46] | Ireland | 67 | 7000 | 0.96 |
Ozakbas [47] | Turkey | 173 | 40,000 | 0.43 |
Polychroniadou [48] | Greece | 44 | 7000 | 0.63 |
Sandi [49] | Hungary | 65 | 20,000 | 0.33 |
Spedo [50] | Brazil | 58 | 30,000 | 0.19 |
Strober [10] | United States | 65 | 400,000 | 0.02 |
Argentina | 50 | 8000 | 0.06 | |
Walker [53] | Canada | 57 | 97,366 | 0.06 |